Lv6
1794 积分 2025-08-24 加入
Novel and future lipid-modulating therapies for the prevention of cardiovascular disease
9小时前
待确认
RNAi-based drug design: considerations and future directions
10小时前
待确认
From lead to market: chemical approaches to transform peptides into therapeutics
11小时前
待确认
Metabolic Stability and Targeted Delivery of Oligonucleotides: Advancing RNA Therapeutics Beyond The Liver
12小时前
待确认
Engineering considerations for next-generation oligonucleotide therapeutics
13小时前
已完结
Advances in oligonucleotide drug delivery
13小时前
已完结
The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications
3天前
已完结
Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial
19天前
已完结
Oligonucleotide therapies for nonalcoholic steatohepatitis
19天前
已完结
Global and Chinese trends in oligonucleotide drug clinical development: A comparative analysis
19天前
已完结
皖公网安备34019202002308
